Company Overview
ALLARITY THERAPEUTICS, INC.
ALLRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-11M
2025 FY
Shares Outstanding
14M
2025 FY
EPS
-0.78USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1860657
Exchange
Nasdaq
Location
US